Study of CMT Nerve-Muscle Signals May Pave Way to Therapy Trial

Study of CMT Nerve-Muscle Signals May Pave Way to Therapy Trial

300446

Study of CMT Nerve-Muscle Signals May Pave Way to Therapy Trial

NMD Pharma, in collaboration with Aarhus University in Denmark and The Ohio State University, initiated an observational study to assess whether Charcot-Marie-Tooth disease (CMT) patients have deficits in the communication between nerve and muscle cells. If confirmed, the company plans to launch clinical trials testing one of its experimental oral ClC-1 inhibitors, meant to improve nerve-muscle communication, in people with CMT type 1 or type 2, the two most common forms of the disease. “This study is…

You must be logged in to read/download the full post.